Xanodyne Pharmaceuticals, Inc.Newport, KY, United States (NASDAQ (GM): XANO Proposed)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Xanodyne Pharmaceuticals Cash Flow Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 06 Dec 05 Dec 04
Net Operating Cash Flow (4.2) (3.9) (19.4)
Net Investing Cash Flow 0.7 (207.6) 0.2
Net Financing Cash Flow 0.5 220.9 19.5
Net Change in Cash (3.0) 9.4 0.3
Depreciation & Amortization 2.4 1.4 0.5
Capital Expenditures (0.2) (0.2) (0.3)
Cash Dividends Paid 0.0 0.0 0.0
Data Definitions